Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL1GB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,687
Award facts
- Contract value 100% obligated
- $16,687.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,687.26 delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 28, 2026. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products across multiple therapeutic domains. Dupixent is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, making this delivery order consistent with the company's role in supplying specialized pharmaceutical commodities to support military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FL1GB?
SPE2DR26FL1GB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FL1GB worth?
The government has obligated $16,687 on SPE2DR26FL1GB.
Is contract SPE2DR26FL1GB an order under another contract?
Yes. SPE2DR26FL1GB is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1GB competed?
The extent of competition for SPE2DR26FL1GB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award